Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Cancer core length from targeted biopsy: an index of prostate cancer volume and pathological stage.

Simopoulos DN, Sisk AE Jr, Priester A, Felker ER, Kwan L, Delfin MK, Reiter RE, Marks LS.

BJU Int. 2019 Aug;124(2):275-281. doi: 10.1111/bju.14691. Epub 2019 Feb 24.

PMID:
30694605
2.

Use of MRI-Guided Biopsy for Selection and Follow-up of Men Undergoing Hemi-gland Cryoablation of Prostate Cancer.

Zhou SR, Simopoulos DN, Jayadevan R, Felker ER, Delfin MK, Barsa DE, Kwan L, Marks LS.

Urology. 2019 Apr;126:158-164. doi: 10.1016/j.urology.2018.11.052. Epub 2019 Jan 16.

3.

MR-guided biopsy and focal therapy: new options for prostate cancer management.

Elkhoury FF, Simopoulos DN, Marks LS.

Curr Opin Urol. 2018 Mar;28(2):93-101. doi: 10.1097/MOU.0000000000000471. Review.

PMID:
29232269
4.

Targeted Prostate Biopsy in the Era of Active Surveillance.

Elkhoury FF, Simopoulos DN, Marks LS.

Urology. 2018 Feb;112:12-19. doi: 10.1016/j.urology.2017.09.007. Epub 2017 Sep 27. Review.

5.

Targeted Prostate Biopsy Using 68Gallium PSMA-PET/CT for Image Guidance.

Simopoulos DN, Natarajan S, Jones TA, Fendler WP, Sisk AE Jr, Marks LS.

Urol Case Rep. 2017 Jun 3;14:11-14. doi: 10.1016/j.eucr.2017.05.006. eCollection 2017 Sep.

6.

Corporeal structural and vascular micro architecture with X-ray micro computerized tomography in normal and diabetic rabbits: histopathological correlation.

Simopoulos DN, Gibbons SJ, Malysz J, Szurszewski JH, Farrugia G, Ritman EL, Moreland RB, Nehra A.

J Urol. 2001 May;165(5):1776-82.

PMID:
11342975
7.

Cholesterol levels in 1,084 healthy New Orleans males.

Simopoulos DN, Ratliff J, Elahi P, Brown M, Waters M, McMahon FG.

J La State Med Soc. 1993 Aug;145(8):346-51.

PMID:
8228545

Supplemental Content

Loading ...
Support Center